9
Apr
Chemence Medical Receives FDA Approval for Exofin Fusion® Redesign
Medical technologies manufacturer improves patient care with enhanced skin closure system Alpharetta, GA — Chemence Medical, a world leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion® skin closure system. Exofin fusion combines a self-adhering flexible mesh strip and a fast-curing 2-octyl … Chemence Medical Receives FDA Approval for Exofin Fusion® Redesign